ARTICLE | Clinical News
Gardasil: Post-marketing study data
October 19, 2009 7:00 AM UTC
Harvard University researchers published a cost-effectiveness analysis in the British Medical Journal showing that HPV vaccination programs for preadolescent girls would result in <$50,000 per quality-adjusted life year (QALY). Including preadolescent boys in the vaccination program generally resulted in cost-effectiveness ratios >$100,000 per QALY. ...